Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tng462 save search
Tango Therapeutics Announces First Patient Dosed in TNG462 Phase 1/2 Trial in Patients With MTAP-deleted Solid Tumors
Published: 2023-07-10 (Crawled : 11:00) - globenewswire.com
TNGX | $7.76 -0.13% -0.13% 360K
|
|
| O: -0.31%
H: 4.4%
C: 0.63%
tng462 tumors trial therapeutics
Tango Therapeutics Announces FDA Clearance of Investigational New Drug Application for TNG462; Provides Additional Business Updates
Published: 2023-01-25 (Crawled : 12:00) - globenewswire.com
TNGX | $7.76 -0.13% -0.13% 360K
|
|
| O: 0.0%
H: 7.58%
C: 0.84%
tng462 fda clearance drug application therapeutics
Tango Therapeutics Announces Presentation of Preclinical Data on PRMT5 Inhibitors TNG908 and TNG462 in Three Abstracts Accepted at 34th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Published: 2022-10-19 (Crawled : 11:00) - globenewswire.com
TNGX | $7.76 -0.13% -0.13% 360K
|
|
| O: 2.95%
H: 0.29%
C: 0.0%
tng908 preclinical symposium therapeutics presentation molecular cancer
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.